Prophylactic treatment in childhood urinary tract infection;Traitement preventif des infections urinaires de l'enfant

Archives de Pediatrie

Volumn 5, Issue SUPPL. 3, 1998, Pages 307-311

  Gaudelus, J ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Children; Prophylactic treatment; Urinary tract infection

Indexed keywords

COTRIMOXAZOLE; NITROFURANTOIN; ANTIINFECTIVE AGENT;

BACTERIUM ADHERENCE; CONFERENCE PAPER; CYSTITIS; FECES MICROFLORA; HUMAN; INFECTION PREVENTION; PATHOPHYSIOLOGY; PROPHYLAXIS; URINARY TRACT INFECTION; VESICOURETERAL REFLUX; ACUTE DISEASE; BACTERIAL INFECTION; CHILD; ENTEROBACTER INFECTION; LONG TERM CARE; MICROBIOLOGICAL EXAMINATION; REVIEW; RISK FACTOR;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; ESCHERICHIA COLI INFECTIONS; HUMANS; LONG-TERM CARE; MICROBIAL SENSITIVITY TESTS; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 0031810516     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(97)89375-X     Document Type: Conference Paper

References (39)

1. Stamm NE, Hooton TM, Johnson JR, Johnson C, Stapleton A, Roberts PL et al. Urinary tract infections : from pathogenesis to treatment. J Infect Dis 1989 ; 159 : 400-6
2. Johnson JR, Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991 ; 4 : 80-128
3. De Man P, Jodal U, Lincoln K, Suanborg-Eden C. Bacterial attachment and inflammation in the urinary tract. J Infect Dis 1988 ; 158 : 29-35
4. Plos K, Connell H, Jodal U, Marklund BI, Marild S, Wettergren B et al. Intestinal carrriage of P fimbriated Escherichia Coli and the susceptibility to urinary tract infection in young children. J Inf Dis 1995 ; 171 : 625-31
5. Schwartz J, Bensman A, Vasmant D, Lasfargues G. Adhésivité bactérienne et infections urinaires récidivantes de l'enfant. Arch Fr Pediatr 1986 ; 43 : 681-4
6. Durbin WA, Peter G. Management of urinary tract infections in infants and children. Pediatr Inf Dis J 1984 ; 3 : 564-74
7. Belman AB, Skoog SJ. Non surgical approach to the management of vesico-ureteral reflux in children. Pediatr Infect Dis J 1989 ; 8 ; 556-9
8. McCracken GH. Options in antimicrobial management of acute urinary tract infections in infants and children. Ped Infect Dis J 1989 ; 8 : 552-5
9. Bensman A, Leroy B. Traitement de l'infection urinaire chez l'enfant. Presse Med 1993 ; 22 : 1916-20
10. Johnson HW, Anderson JD, Keith Chambers G, Arnold WJD, Irwin BJ, Brinton JR. A short term study of nitrofurantoin prophylaxis in children managed with clean intermittent catheterization. Pediatrics 1994 ; 93 : 752-5
11. Fox BC, Solinger HW, Belzer FO, Maki DG. A prospective, randomized double-blind study of trimethoprim sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora and the cost benefit of prophylaxis. Amer J Med 1990 ; 89 : 255-74
12. Guibert J. Prophylaxie des infections urinaires récidivantes. Med Mal Infect 1991 ; 21 : 160-7
13. Koff S A, Murtagh DS. The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution. J Urol 1983 ; 130 : 1138-41
14. Sorensen K, Lose G, Nathan E. Urinary tract infections and diurnal incontinence in girls. Eur J Pediatr 1988 ; 148 : 146-7
15. Shortliffe LM. The management of urinary tract infections in children without urinary tract abnormalities. Urol Clin North Am 1995 ; 22 : 67-73
16. Desnottes JF, Diallo N, Moret F, Santoja R. Effect of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells. Drugs Exp Clin Res 1987 ; 12 : 69-73
17. Desnotttes JF, Leroy D, Diallo N. Effects of subminimal inhibitory concentrations of pefloxacin on the piliation and adherence of E coli. Drugs Exp Clin Res 1988 ; 14 : 625-34
18. Jodal U, Winberg J. Management of children with unobstructed urinary tract infection. Pediatr Nephrol 1987 ; 1 : 647-56
19. Smellie JM, Gruneberg RN, Leakey A, Atkin WS. Long term low dose cotrimoxazole in prophylaxis of chilhood urinary tract infection: clinical aspects. Br Med J 1976 ; 2 : 203-6
20. Gruneberg RN, Smellie JM, Leakey A, Atkin WS. Long term low dose cotrimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects. Br Med J 1976 ; 2 : 206-8
21. Smellie JM, Katz G, Gruneberg RN. Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet 1978 ; ii : 175-8
22. Carlsen NLT, Hesselberg U, Glenting P. Comparison of low dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children. J Antimicrob Chemother 1985 ; 16 : 509-17
23. Bailey RR. The management of grades I and II (non dilating) vesicoureteral reflux. J Urol 1992 ; 148 : 1693-5
24. Winberg J. Progressive renal damage from infection with or without reflux. J Urol 1992 ; 148 : 1733-4
25. Kunin CM. Chemoprophylaxis and suppressive therapy in the management of urinary tract infections. J Antimicrob Chemother 1994 ; 33 (suppl A) : 51-62
26. Edwards D, Normand ICS, Prescod N, Smellie JM. Disappearance of vesico-ureteric reflux during long term prophylaxis of urinary tract infection in children. Br Med J 1977 ; 2 : 285-8
27. Schlappy P, Paunier L, Cuendet A. Prophylaxie des infections urinaires récidivantes de l'enfant. Emploi à long terme d'une faible dose de trimethoprime-sulfamethoxazole. Helv Paediatr Acta 1981 ; 36 : 241-9
28. Holland NH, Kazee M, Duff D, McRoberts W. Antimicrobial prophylaxis in children with urinary tract infection and vesico-ureteral reflux. Rev Infect Dis 1982 ; 4 : 467-74
29. Reddy PP, Evans MT, Hughes PA Dangman B, Cooper J, Lepow ML et al. Antimicrobial prophylaxis in children with vesico-ureteral reflux: a randomized prospective study of continuous therapy vs intermittent vs surveillance. Pediatrics 1997 ; 100 (suppl) : 555-6
30. Holmberg L, Boman G, Böttinger LE, Eriksson B, Spross R, Wessling A et al. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980 ; 69 : 733-8
31. Broughton RA, Wilson HD. Nitrofurantoin pulmonary toxicity in a child. Pediatr Infect Dis J 1986 ; 5 : 466-9
32. Corragio MJ, Gross TP, Roscelli JD, Nitrofurantoin toxicity in children. Pediatr Infect Dis J 1989 ; 8 : 163-6
33. Smellie J, Gruneberg RN, Bantock HM, Prescod N. Prophylactic cotrimazole and trimetoprim in the management of urinary tract infection in children. Pediatr Nephrol 1988 ; 2 : 12-7
34. Gutman LT. The use of trimethoprim-sulfamethoxazole in children: a review of adverse reactions and indications. Pediatr Infect Dis J 1984 ; 4 : 349-57
35. Uhari M, Nuutinen M, Turtinen J. Adverse reactions in children during long term antimicrobial therapy. Pediatr Infect Dis J 1996 ; 15 : 404-8
36. Nuutinen M, Turtinen J, Uhari M. Growth and joint symptoms in children treated with nalidixic acid. Pediatr Infect Dis J 1994 ; 13 : 798-800
37. Brumfitt W, Hamilton-Miller JMT. A comparative trial of low dose Cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection 1995 ; 23 : 98-102
38. Nord CE, Heimdahl A, Lundberg C, Marklund G. Impact of cefaclor on the normal human oropharyngeal and intestinal microflora. Scand J Infect Dis 1987 ; 19 : 681-5
39. Nord CE, Edlund C. Impact of antimicrobial agents on human intestinal microflora. J Chemother 1990 ; 2 : 218-37